Date | Time | Source | Headline | Symbol | Company |
06/17/2024 | 1:31AM | GlobeNewswire Inc. | Vallourec wins a new 5-year contract to provide premium solutions to Equinor in Brazil | | |
06/17/2024 | 1:31AM | GlobeNewswire Inc. | Vallourec remporte un nouveau contrat de 5 ans avec Equinor pour la fourniture de solutions premium au Brésil | | |
06/17/2024 | 1:31AM | GlobeNewswire Inc. | Vallourec wins a new 5-year contract to provide premium solutions to Equinor in Brazil | EU:VK | Vallourec |
06/17/2024 | 1:31AM | Alliance News | Alliance News UK - start of day | | |
06/17/2024 | 1:30AM | Business Wire | Prodapt launches TechCo Toolkit to accelerate digital transformation with ServiceNow for Communications Service Providers | | |
06/17/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (EUR): NAV(s) | EU:BGHL | Boussard And Gavaudan Holding Limited |
06/17/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (GBP): NAV(s) | EU:BGHS | Boussard and Gavaudan Holding |
06/17/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (EUR): NAV(s) | LSE:BGHL | Boussard & Gavaudan Holding Limited |
06/17/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (GBP): NAV(s) | LSE:BGHS | Boussard & Gavaudan Holding Limited |
06/17/2024 | 1:30AM | PR Newswire (US) | XRP Healthcare Magazine Issue 3: Featuring Ugandan Innovator Peter Waiswa, NHS Collaborator ISANSYS, Ehlers-Danlos Society & Top 10 African Hospitals | | |
06/17/2024 | 1:30AM | PR Newswire (US) | XRP Healthcare Magazine Issue 3: Featuring Ugandan Innovator Peter Waiswa, NHS Collaborator ISANSYS, Ehlers-Danlos Society & Top 10 African Hospitals | | |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | Corbion reports the progress of its € 20 million share buyback program 10 June – 14 June 2024 | EU:CRBN | Corbion N.V. |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | Corbion reports the progress of its € 20 million share buyback program 10 June – 14 June 2024 | TG:CSUA | Corbion N.V. |
06/17/2024 | 1:00AM | Business Wire | New Survey from Canva, MMA Global Finds Senior Marketers See Creative Output as a Top Priority, Despite Investment Gaps and Shrinking Talent Pool | | |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | Ackermans & van Haare invests in V.Group, a leading provider of marine support services | EU:ACKB | Ackermans and Van Haaren NV |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | Start of Day Message | | |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024 | EU:ARGX | Argen X SE |
06/17/2024 | 1:00AM | Business Wire | Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial | NASDAQ:IPHA | Innate Pharma SA |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | ING Capital Markets Day 2024: ‘Growing the difference’ | XE:INN1 | ING Groep NV |
06/17/2024 | 1:00AM | Business Wire | Innate Pharma partage de nouveaux résultats concernant l’essai de Phase 1/2 mené par Sanofi évaluant le NK cell engager SAR443579/IPH6101 dans divers cancers du sang | EU:IPH | Innate Pharma |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | ING Capital Markets Day 2024: ‘Growing the difference’ | EU:INGA | ING Groep NV |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit | NASDAQ:MOLN | Molecular Partners AG |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024 | NASDAQ:ARGX | argenx SE |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | ING Capital Markets Day 2024: ‘Growing the difference’ | BIT:INGA | ING Groep NV |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | ING Capital Markets Day 2024: ‘Growing the difference’ | EU:INGA | ING Groep NV |
06/17/2024 | 1:00AM | Business Wire | Teledyne FLIR Defense Announces New SUGV 325 Portable, Modular Robot | NYSE:TDY | Teledyne Technologies Inc |
06/17/2024 | 1:00AM | Business Wire | Innate Pharma partage de nouveaux résultats concernant l’essai de Phase 1/2 mené par Sanofi évaluant le NK cell engager SAR443579/IPH6101 dans divers cancers du sang | NASDAQ:IPHA | Innate Pharma SA |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | Ackermans & van Haare invests in V.Group, a leading provider of marine support services | TG:B3K | Ackermans and Van Haaren NV |
06/17/2024 | 1:00AM | GlobeNewswire Inc. | Ackermans & van Haaren investit dans V.Group, un fournisseur de services de premier plan pour l'industrie du transport maritime | EU:ACKB | Ackermans and Van Haaren NV |
06/17/2024 | 1:00AM | Business Wire | Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial | EU:IPH | Innate Pharma |